Firefly Current Deferred Revenue vs Total Liab Analysis

AIFF Stock

3.09 0.09 3.00%

Firefly Neuroscience, financial indicator trend analysis is much more than just examining Firefly Neuroscience, latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Firefly Neuroscience, is a good investment. Please check the relationship between Firefly Neuroscience, Current Deferred Revenue and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Firefly Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more detail on how to invest in Firefly Stock please use our How to Invest in Firefly Neuroscience, guide.

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Firefly Neuroscience, Current Deferred Revenue account and Total Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Firefly Neuroscience,'s Current Deferred Revenue and Total Liab is -0.79. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Liab in the same time period over historical financial statements of Firefly Neuroscience,, assuming nothing else is changed. The correlation between historical values of Firefly Neuroscience,'s Current Deferred Revenue and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Firefly Neuroscience, are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Current Deferred Revenue i.e., Firefly Neuroscience,'s Current Deferred Revenue and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.79

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Firefly Neuroscience,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Firefly Neuroscience, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Firefly Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more detail on how to invest in Firefly Stock please use our How to Invest in Firefly Neuroscience, guide.The Firefly Neuroscience,'s current Tax Provision is estimated to increase to 2,100, while Selling General Administrative is projected to decrease to roughly 3.3 M.

Firefly Neuroscience, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.62	-0.14	-0.22	0.84	0.39	0.18	-0.72	0.55	-0.11	0.9	0.26	0.03	-0.01	0.9	0.67	-0.7	0.17	-0.54	-0.12	0.94	-0.68	0.64	-0.16	0.08	0.38
Short Long Term Debt Total	-0.62		0.48	0.73	-0.85	0.25	-0.57	0.79	-0.67	0.49	-0.58	0.25	0.3	-0.36	-0.58	-0.72	0.73	0.28	0.62	0.7	-0.72	0.97	-0.72	0.31	-0.3	-0.24
Other Current Liab	-0.14	0.48		0.88	-0.56	-0.21	-0.95	0.07	-0.88	0.87	-0.09	0.69	0.9	-0.6	-0.09	-0.82	0.8	0.7	0.9	0.85	-0.43	0.64	-0.84	0.91	-0.92	-0.84
Total Current Liabilities	-0.22	0.73	0.88		-0.71	0.18	-0.83	0.45	-0.83	0.85	-0.31	0.69	0.7	-0.62	-0.31	-0.79	0.76	0.72	0.83	0.99	-0.52	0.81	-0.81	0.69	-0.68	-0.61
Total Stockholder Equity	0.84	-0.85	-0.56	-0.71		0.14	0.55	-0.81	0.82	-0.5	0.83	-0.15	-0.31	0.28	0.83	0.9	-0.91	-0.23	-0.82	-0.64	0.96	-0.93	0.88	-0.45	0.38	0.57
Property Plant And Equipment Net	0.39	0.25	-0.21	0.18	0.14		0.22	0.32	0.37	-0.13	0.18	0.06	-0.33	0.09	0.18	0.37	-0.39	0.02	-0.39	0.27	0.34	0.07	0.36	-0.5	0.45	0.65
Current Deferred Revenue	0.18	-0.57	-0.95	-0.83	0.55	0.22		-0.06	0.88	-0.88	0.05	-0.71	-0.94	0.7	0.05	0.82	-0.8	-0.72	-0.86	-0.79	0.42	-0.69	0.84	-0.92	0.94	0.76
Net Debt	-0.72	0.79	0.07	0.45	-0.81	0.32	-0.06		-0.36	0.11	-0.85	-0.12	-0.22	0.0	-0.85	-0.48	0.49	-0.05	0.35	0.43	-0.75	0.74	-0.45	-0.12	0.18	-0.02
Retained Earnings	0.55	-0.67	-0.88	-0.83	0.82	0.37	0.88	-0.36		-0.85	0.49	-0.57	-0.79	0.64	0.49	0.98	-0.97	-0.62	-0.99	-0.76	0.77	-0.81	0.99	-0.88	0.84	0.88
Accounts Payable	-0.11	0.49	0.87	0.85	-0.5	-0.13	-0.88	0.11	-0.85		-0.17	0.92	0.91	-0.91	-0.17	-0.74	0.69	0.94	0.8	0.84	-0.4	0.59	-0.77	0.89	-0.88	-0.74
Cash	0.9	-0.58	-0.09	-0.31	0.83	0.18	0.05	-0.85	0.49	-0.17		0.13	0.12	0.07	1.0	0.59	-0.6	0.03	-0.48	-0.24	0.91	-0.62	0.57	-0.07	-0.03	0.32
Non Current Assets Total	0.26	0.25	0.69	0.69	-0.15	0.06	-0.71	-0.12	-0.57	0.92	0.13		0.83	-0.94	0.13	-0.41	0.35	0.99	0.5	0.72	-0.02	0.29	-0.45	0.73	-0.74	-0.5
Non Currrent Assets Other	0.03	0.3	0.9	0.7	-0.31	-0.33	-0.94	-0.22	-0.79	0.91	0.12	0.83		-0.8	0.12	-0.67	0.64	0.83	0.76	0.68	-0.22	0.43	-0.7	0.96	-0.98	-0.78
Other Assets	-0.01	-0.36	-0.6	-0.62	0.28	0.09	0.7	0.0	0.64	-0.91	0.07	-0.94	-0.8		0.07	0.5	-0.45	-0.95	-0.54	-0.63	0.21	-0.39	0.54	-0.74	0.72	0.52
Cash And Short Term Investments	0.9	-0.58	-0.09	-0.31	0.83	0.18	0.05	-0.85	0.49	-0.17	1.0	0.13	0.12	0.07		0.59	-0.6	0.03	-0.48	-0.24	0.91	-0.62	0.57	-0.07	-0.03	0.32
Net Receivables	0.67	-0.72	-0.82	-0.79	0.9	0.37	0.82	-0.48	0.98	-0.74	0.59	-0.41	-0.67	0.5	0.59		-1.0	-0.48	-0.98	-0.72	0.86	-0.87	1.0	-0.79	0.74	0.84
Common Stock Shares Outstanding	-0.7	0.73	0.8	0.76	-0.91	-0.39	-0.8	0.49	-0.97	0.69	-0.6	0.35	0.64	-0.45	-0.6	-1.0		0.41	0.97	0.68	-0.87	0.87	-0.99	0.76	-0.72	-0.82
Other Current Assets	0.17	0.28	0.7	0.72	-0.23	0.02	-0.72	-0.05	-0.62	0.94	0.03	0.99	0.83	-0.95	0.03	-0.48	0.41		0.56	0.74	-0.11	0.34	-0.51	0.76	-0.75	-0.55
Other Stockholder Equity	-0.54	0.62	0.9	0.83	-0.82	-0.39	-0.86	0.35	-0.99	0.8	-0.48	0.5	0.76	-0.54	-0.48	-0.98	0.97	0.56		0.76	-0.77	0.79	-0.99	0.86	-0.82	-0.91
Total Liab	-0.12	0.7	0.85	0.99	-0.64	0.27	-0.79	0.43	-0.76	0.84	-0.24	0.72	0.68	-0.63	-0.24	-0.72	0.68	0.74	0.76		-0.44	0.76	-0.74	0.64	-0.64	-0.54
Total Current Assets	0.94	-0.72	-0.43	-0.52	0.96	0.34	0.42	-0.75	0.77	-0.4	0.91	-0.02	-0.22	0.21	0.91	0.86	-0.87	-0.11	-0.77	-0.44		-0.82	0.84	-0.41	0.32	0.6
Short Term Debt	-0.68	0.97	0.64	0.81	-0.93	0.07	-0.69	0.74	-0.81	0.59	-0.62	0.29	0.43	-0.39	-0.62	-0.87	0.87	0.34	0.79	0.76	-0.82		-0.86	0.48	-0.46	-0.46
Common Stock	0.64	-0.72	-0.84	-0.81	0.88	0.36	0.84	-0.45	0.99	-0.77	0.57	-0.45	-0.7	0.54	0.57	1.0	-0.99	-0.51	-0.99	-0.74	0.84	-0.86		-0.81	0.77	0.85
Net Invested Capital	-0.16	0.31	0.91	0.69	-0.45	-0.5	-0.92	-0.12	-0.88	0.89	-0.07	0.73	0.96	-0.74	-0.07	-0.79	0.76	0.76	0.86	0.64	-0.41	0.48	-0.81		-0.99	-0.92
Property Plant And Equipment Gross	0.08	-0.3	-0.92	-0.68	0.38	0.45	0.94	0.18	0.84	-0.88	-0.03	-0.74	-0.98	0.72	-0.03	0.74	-0.72	-0.75	-0.82	-0.64	0.32	-0.46	0.77	-0.99		0.87
Short Long Term Debt	0.38	-0.24	-0.84	-0.61	0.57	0.65	0.76	-0.02	0.88	-0.74	0.32	-0.5	-0.78	0.52	0.32	0.84	-0.82	-0.55	-0.91	-0.54	0.6	-0.46	0.85	-0.92	0.87

Click cells to compare fundamentals

Firefly Neuroscience, Account Relationship Matchups

Currently Active Assets on Macroaxis

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix
EPGFX	Europac Gold Fund
FTGFF	Firan Technology Group

When determining whether Firefly Neuroscience, is a strong investment it is important to analyze Firefly Neuroscience,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Firefly Neuroscience,'s future performance. For an informed investment choice regarding Firefly Stock, refer to the following important reports:

How To Invest In Firefly

Details

Is Firefly Stock a good investment?

Details

What is Firefly Neuroscience,'s Net Worth?

Details

Largest IT Consulting & Other Services Companies

View

Largest Software - Application Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Firefly Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more detail on how to invest in Firefly Stock please use our How to Invest in Firefly Neuroscience, guide.

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Firefly Neuroscience,. If investors know Firefly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Firefly Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.30)

Revenue Per Share

0.001

Quarterly Revenue Growth

(0.98)

The market value of Firefly Neuroscience, is measured differently than its book value, which is the value of Firefly that is recorded on the company's balance sheet. Investors also form their own opinion of Firefly Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Firefly Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Firefly Neuroscience,'s market value can be influenced by many factors that don't directly affect Firefly Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Firefly Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Firefly Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Firefly Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Firefly Current Deferred Revenue vs Total Liab Analysis

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Total Liab

Firefly Neuroscience, fundamental ratios Correlations

Firefly Neuroscience, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Net Receivables
Total Liab	+ 0.99	Total Current Liabilities
Common Stock	+ 0.99	Retained Earnings
Other Current Assets	+ 0.99	Non Current Assets Total
Net Receivables	+ 0.98	Retained Earnings

Common Stock Shares Outstanding	- 1.0	Net Receivables
Property Plant And Equipment Gross	- 0.99	Net Invested Capital
Common Stock	- 0.99	Other Stockholder Equity
Common Stock	- 0.99	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.98	Net Receivables